— Research monograph
GLOW Blend (BPC-157 · GHK-Cu · TB-500)
A three-peptide repair + skin-signaling co-formulation in one vial.
- Class
- Merit co-formulation: BPC-157 + GHK-Cu + TB-500 (Thymosin Beta-4 fragment)
- Half-life (research)
- Component-dependent (see the individual BPC-157, GHK-Cu, and TB-500 records).
- Origin
- GLOW is a Merit-specific co-formulation rather than a single characterized molecule. Each component carries its own research record: BPC-157 (Sikiric laboratory, University of Zagreb, early 1990s), GHK-Cu (Pickart, 1973), and TB-500 / Thymosin Beta-4 (Goldstein, 1981).
- Solubility
- Water-soluble; reconstitutes in bacteriostatic water.
What is GLOW Blend (BPC-157 · GHK-Cu · TB-500)?
GLOW combines three peptides that recur in tissue-repair and extracellular-matrix research: BPC-157, a stable gastric pentadecapeptide; GHK-Cu, a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied in collagen and remodeling contexts; and TB-500, a synthetic fragment of the actin-binding peptide Thymosin Beta-4.
Because GLOW is a co-formulation, it has no separate published literature of its own — the relevant research belongs to each component. Merit supplies it as a single research preparation for laboratory use only.
How does GLOW Blend (BPC-157 · GHK-Cu · TB-500) work?
Component-level: BPC-157 is studied for cytoprotective and angiogenic signaling; GHK-Cu for copper-dependent modulation of extracellular-matrix and remodeling genes; TB-500 for actin sequestration and cell-migration pathways. No combined mechanism is established for the blend.
Research applications
- Tissue-repair pathway research (component-based)
- Extracellular-matrix and collagen models
- Angiogenesis and cell-migration studies
- Comparative peptide co-formulation research
Handling & reconstitution
GLOW Blend (BPC-157 · GHK-Cu · TB-500) ships as a sealed, lyophilized (freeze-dried) powder and is reconstituted with bacteriostatic water for laboratory handling. Water-soluble; reconstitutes in bacteriostatic water. Concentration equals vial mass divided by diluent volume.
See the Glow blend reconstitution protocol for a step-by-step guide and an interactive research calculator (vial size → diluent → draw volume).
Frequently asked questions
What is GLOW Blend (BPC-157 · GHK-Cu · TB-500)?
GLOW combines three peptides that recur in tissue-repair and extracellular-matrix research: BPC-157, a stable gastric pentadecapeptide; GHK-Cu, a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) studied in collagen and remodeling contexts; and TB-500, a synthetic fragment of the actin-binding peptide Thymosin Beta-4. Merit supplies it as a lyophilized research compound for research use only — not for human or veterinary use.
How does GLOW Blend (BPC-157 · GHK-Cu · TB-500) work?
Component-level: BPC-157 is studied for cytoprotective and angiogenic signaling; GHK-Cu for copper-dependent modulation of extracellular-matrix and remodeling genes; TB-500 for actin sequestration and cell-migration pathways. No combined mechanism is established for the blend. Mechanistic descriptions summarize published preclinical findings and are not clinical claims.
What is the half-life of GLOW Blend (BPC-157 · GHK-Cu · TB-500)?
Component-dependent (see the individual BPC-157, GHK-Cu, and TB-500 records). Values reflect preclinical or research-context reports, not clinical pharmacokinetics.
How is GLOW Blend (BPC-157 · GHK-Cu · TB-500) reconstituted for research?
A lyophilized vial is reconstituted with bacteriostatic water; concentration equals vial mass divided by diluent volume. See the GLOW Blend (BPC-157 · GHK-Cu · TB-500) reconstitution protocol for a step-by-step guide and a research calculator.
Is Merit GLOW Blend (BPC-157 · GHK-Cu · TB-500) for human use?
No. It is sold strictly for research use only — not for human or veterinary use, and not for diagnostic or therapeutic use. Every lot ships with a certificate of analysis documenting ≥99% HPLC purity.
References
- Stable gastric pentadecapeptide BPC 157 in the treatment of various organ lesions (review). Sikiric P, Seiwerth S, Rucman R, et al.. Current Pharmaceutical Design, 2011 · doi:10.2174/138161211796196907
- The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging. Pickart L, Margolina A. Oxidative Medicine and Cellular Longevity, 2012 · doi:10.1155/2012/324832
For research use only. Not for human or veterinary use. Not FDA-approved. Reference information summarized from published literature — not medical or dosing advice.
— Keep reading